Three years after AbbVie stood at the edge of a major patent cliff with the loss of exclusivity for immunology ...
Skyrizi was the top Rx and over-the-counter (OTC) pharma brand advertising on TV in 2024, according to data released by iSpot.tv on Thursday afternoon. AbbVie’s psoriasis, ulcerative colitis, Crohn’s ...
AbbVie Inc. raised its full-year profit forecast after quarterly results beat estimates, a sign of confidence amid growing ...
NORTH CHICAGO, Ill., June 18, 2024 /PRNewswire/ -- AbbVie (ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved SKYRIZI ® (risankizumab-rzaa) for adults with moderately to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results